Sanwa Chemical Combo Diabetes Drug Seible Obtains Approval
This article was originally published in PharmAsia News
Executive Summary
Tokyo-based Sanwa Chemical Nov. 9 announced that its combo drug Seible (miglitol/biguanides) for diabetes was approved in Japan